Affiliation:
1. University of Florida
2. University of Mississippi School of Pharmacy
3. Centre de recherches sur la cognition animale
Abstract
Abstract
The Neuropeptide FF (NPFF) receptor system has been implicated in mediating opioid-induced hyperalgesia and tolerance. Understanding the structural features that contribute to high binding affinity of ligands to the NPFF receptors could help in identifying potent and selective NPFF-R probes. We conducted a structure-activity relationship (SAR) study targeting the guanidine functionality of our previously identified lead molecule MES304 in order to probe the guanidine binding site of the NPFF receptors. By applying several rigidifying modifications and substitutions on the guanidine moiety, we concluded that while the guanidine group is optimal for strong binding affinity at both receptor subtypes (NPFF1-R/NPFF2-R), other groups may be tolerated. Compound 17b, in which the guanidine was replaced with a piperidine ring, displayed robust binding affinity at both receptor subtypes (Ki < 300 nM) despite lacking a guanidine group. This indicated that strong binding to the NPFF receptors can be achieved with analogues devoid of guanidine.
Publisher
Research Square Platform LLC
Reference13 articles.
1. Identification and characterization of two G protein-coupled receptors for neuropeptide FF;Bonini JA;J Biol Chem,2000
2. Pharmacological characterization of human NPFF1 and NPFF2 receptors expressed in CHO cells by using NPY Y1 receptor antagonists;Mollereau C;Eur J Pharmacol,2002
3. Yang HY, Fratta W, Majane EA, Costa E (1985) Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. U.S.A. 82, 7757
4. Neuropeptide FF reduces food intake in rats;Murase T;Peptides,1996
5. Mechanisms underlying the cardiovascular responses to peripheral administration of NPFF in the rat;Allard M;J Pharmacol Exp Ther,1995